KFM: Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type
What it covers
(a) Nonroller-type cardiopulmonary and circulatory bypass blood pump—(1) Identification. A nonroller-type cardiopulmonary and circulatory bypass blood pump is a prescription device that uses a method other than revolving rollers to pump the blood through an extracorporeal circuit for periods lasting less than 6 hours for the purpose of providing either:
(i) Full or partial cardiopulmonary bypass (i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or
(ii) Temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.
(2) Classification—Class II (special controls). The special controls for this device are:
(i) Non-clinical performance testing must perform as intended over the intended duration of use and demonstrate the following: Operating parameters, dynamic blood damage, heat generation, air entrapment, mechanical integrity, and durability/reliability;
(ii) The patient-contacting components of the device must be demonstrated to be biocompatible;
(iii) Sterility and shelf life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components; and
(iv) Labeling must include information regarding the duration of use, and a detailed summary of the device- and procedure-related complications pertinent to use of the device.
The identification in 21 CFR 870.4360, nonroller-type blood pump. FDA gives KFM no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K251762 | Quantum Perfusion Centrifugal Blood Pump CP20NG with Integrated Sensors (CP20V-NG) | Spectrum Medical S.R.L. | Aug 4, 2025 | Traditional |
| K250326 | Quantum Perfusion Centrifugal Blood Pump CP22NG with Integrated Sensors (CP22V-NG) | Spectrum Medical S.R.L. | Jun 24, 2025 | Traditional |
| K233091 | Quantum Perfusion Centrifugal Blood Pump CP37 with Integrated Sensors (CP37V-VT); Quantum Perfusion Centrifugal Blood Pump CP22 with Integrated Sensors (CP22V-VT) | Qura S.R.L | Oct 26, 2023 | Special |
| K232132 | LifeSPARC System | Cardiacassist, Inc. | Aug 3, 2023 | Special |
| K220842 | Quantum Perfusion Centrifugal Blood Pump CP22 with Integrated Sensors, Quantum Perfusion Centrifugal Blood Pump CP20 with Integrated Sensors | Qura S.R.L | May 19, 2023 | Traditional |
| K200091 | Capiox iCP Centrifugal Pump | Terumo Cardiovascular Systems Corporation | Nov 18, 2021 | Traditional |
| K201320 | Quantum PureFlow Centrifugal Blood Pump CP22 with Integrated Sensor | Qura S.R.L | Nov 3, 2021 | Traditional |
| K193663 | FloPump 57mL Centrifugal Pump | International Biophysics Corporation | Mar 10, 2021 | Traditional |
| K202169 | Quantum PureFlow Centrifugal Blood Pump CP37, Quantum PureFlow Centrifugal Blood Pump CP22 | Qura S.R.L | Sep 2, 2020 | Special |
| K201068 | Affinity CP Centrifugal Blood Pump, Affinity CP Centrifugal Blood Pump with Balance Biosurface, Affinity CP Centrifugal Blood Pump with Cortiva BioActive Surface | Medtronic, Inc. | May 21, 2020 | Special |
Clearances by year
24 KFM 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 2 | 98 |
| 2023 | 3 | 30 |
| 2021 | 3 | 534 |
| 2020 | 3 | 30 |
| 2019 | 3 | 147 |
| 2017 | 1 | 345 |
| 2013 | 2 | 51 |
| 2011 | 7 | 16 |
Who submits
11 applicants cleared a KFM device since 2011. 67% of the clearances went to applicants in United States, then Italy (33%). By type: Traditional 58% and Special 42%.
| Applicant | Clearances since 2011 |
|---|---|
| Medtronic, Inc. | 6 |
| Qura S.R.L | 5 |
| Cardiacassist, Inc. | 3 |
| International Biophysics Corporation | 2 |
| Spectrum Medical S.R.L. | 2 |
| Abiomed, Inc. | 1 |
| Lifebridge Medizintechnik AG | 1 |
| Maquet Cardiopulmonary, AG | 1 |
How FDA classifies it
(b) Nonroller-type temporary ventricular support blood pump—(1) Identification. A nonroller-type temporary ventricular support blood pump is a prescription device that uses any method resulting in blood propulsion to provide the temporary ventricular assistance required for support of the systemic and/or pulmonary circulations during periods when there is ongoing or anticipated hemodynamic instability due to immediately reversible alterations in ventricular myocardial function resulting from mechanical or physiologic causes. Duration of use would be less than 6 hours.
(2) Classification. Class III (premarket approval).
From 21 CFR 870.4360. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.4360 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KFM clearances declared.
Ask about KFM
Questions about KFM
What is FDA product code KFM?
Product code KFM, “Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type” in FDA's classification database, is a Class II device type under 21 CFR 870.4360 (nonroller-type blood pump), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 84 clearances under KFM, 24 of them since 2011.
How many 510(k) clearances are there under KFM?
FDA’s 510(k) database listed 84 clearances under KFM as of Oct 29, 2026, 24 of them decided since 2011; the most recent decision was Aug 4, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a KFM 510(k)?
For the 2 KFM clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 98 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KFM clearances?
Since 2011: Medtronic, Inc. (6), Qura S.R.L (5), Cardiacassist, Inc. (3), International Biophysics Corporation (2) and Spectrum Medical S.R.L. (2). 11 applicants have cleared a KFM device in that time.